193 related articles for article (PubMed ID: 35280773)
1. HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.
Huang Z; Yang J; Qiu W; Huang J; Chen Z; Han Y; Ye C
Front Oncol; 2022; 12():829777. PubMed ID: 35280773
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
[TBL] [Abstract][Full Text] [Related]
3. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
Zheng C; Guo H; Mo Y; Liu G
Recent Pat Anticancer Drug Discov; 2023 Aug; ():. PubMed ID: 37653627
[TBL] [Abstract][Full Text] [Related]
4. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract][Full Text] [Related]
5. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.
Yuan R; Zhang Y; Wang Y; Chen H; Zhang R; Hu Z; Chai C; Chen T
Front Immunol; 2023; 14():1152678. PubMed ID: 37215111
[TBL] [Abstract][Full Text] [Related]
6. ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.
Ding Y; Herman JA; Toledo CM; Lang JM; Corrin P; Girard EJ; Basom R; Delrow JJ; Olson JM; Paddison PJ
Oncotarget; 2017 Jul; 8(30):48545-48562. PubMed ID: 28596487
[TBL] [Abstract][Full Text] [Related]
7. UBE2C as an Immune-Related Biomarker for Breast Cancer: A Study Based on Multiple Databases.
Cui Y; Wang HZ; Song Y; Yang S; Sai FY; Yu DJ
Chin Med Sci J; 2024 May; ():. PubMed ID: 38828693
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients.
Cui S; Feng J; Tang X; Lou S; Guo W; Xiao X; Li S; Chen X; Huan Y; Zhou Y; Xiao L
Eur J Med Res; 2023 Feb; 28(1):90. PubMed ID: 36805828
[TBL] [Abstract][Full Text] [Related]
9. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
Ling J; Peng N; Luo L
J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
[TBL] [Abstract][Full Text] [Related]
10. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
11. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
[TBL] [Abstract][Full Text] [Related]
12. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
Xu Q; Chen S; Hu Y; Huang W
Front Immunol; 2021; 12():711433. PubMed ID: 34512634
[TBL] [Abstract][Full Text] [Related]
13. HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer.
Zhao D; Li W; Wang Y; Zhang G; Bai X; Yu H
Transl Cancer Res; 2023 Dec; 12(12):3503-3521. PubMed ID: 38197075
[TBL] [Abstract][Full Text] [Related]
14. Spatial and single-cell explorations uncover prognostic significance and immunological functions of mitochondrial calcium uniporter in breast cancer.
Li CJ; Tzeng YT; Hsiao JH; Tseng LM; Hsu TS; Chu PY
Cancer Cell Int; 2024 Apr; 24(1):140. PubMed ID: 38632642
[TBL] [Abstract][Full Text] [Related]
15. ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.
Wang J; Zhang X; Li J; Ma X; Feng F; Liu L; Wu J; Sun C
Aging (Albany NY); 2020 Nov; 13(1):351-363. PubMed ID: 33234738
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
[No Abstract] [Full Text] [Related]
17. CD40LG as a Prognostic Molecular Marker Regulates Tumor Microenvironment Through Immune Process in Breast Cancer.
Yuan M; Pei J; Li R; Tian L; He X; Li Y
Int J Gen Med; 2021; 14():8833-8846. PubMed ID: 34858051
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.
Zhu Z; Ye W; Wu X; Lin S; Xu J; Li L; Li J; Wang H; Huang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350431
[TBL] [Abstract][Full Text] [Related]
19. EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer.
Li K; Tan G; Zhang X; Lu W; Ren J; Si Y; Adu-Gyamfi EA; Li F; Wang Y; Xie B; Wang M
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551184
[TBL] [Abstract][Full Text] [Related]
20. GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis.
Zeng J; Yi J; Tan S; Zeng Y; Zou L; Zhang C; Liu L; Yi P; Fan P; Yu J
Front Endocrinol (Lausanne); 2022; 13():995972. PubMed ID: 36246907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
